Shenzhen - Delayed Quote CNY
Newland Pharmaceutical Co., Ltd. (301277.SZ)
11.81
-0.69
(-5.52%)
At close: 3:04:16 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
761,642.16
726,437.01
651,436.76
627,364.05
513,837.36
Cost of Revenue
460,691.96
431,855.59
391,922.70
404,007.17
307,817.98
Gross Profit
300,950.20
294,581.42
259,514.06
223,356.88
206,019.38
Operating Expense
103,361.96
103,220.22
98,987.03
74,083.04
55,687.12
Operating Income
197,588.24
191,361.20
160,527.03
149,273.84
150,332.26
Net Non Operating Interest Income Expense
1,737.23
2,569.49
2,531.89
-5,528.86
-6,527.34
Pretax Income
201,792.17
197,350.62
181,164.95
142,882.21
131,935.24
Tax Provision
27,652.57
24,338.73
23,962.97
11,174.37
17,111.58
Net Income Common Stockholders
174,282.32
173,629.22
158,979.23
132,304.59
114,978.16
Basic EPS
0.44
0.44
0.41
0.44
0.39
Diluted EPS
0.44
0.44
0.41
0.44
0.39
Basic Average Shares
392,882.36
392,065.99
390,475.31
301,531.40
293,944.16
Diluted Average Shares
392,882.36
392,065.99
390,475.31
301,531.40
293,944.16
Total Operating Income as Reported
203,178.45
198,591.76
182,757.64
142,618.57
132,514.06
Total Expenses
564,053.92
535,075.81
490,909.73
478,090.21
363,505.10
Net Income from Continuing & Discontinued Operation
174,282.32
173,629.22
158,979.23
132,304.59
114,978.16
Normalized Income
182,896.58
182,018.87
156,625.37
133,520.58
124,697.01
Interest Income
2,037.29
2,718.81
2,704.35
1,173.78
256.35
Interest Expense
188.58
89.32
132.85
6,622.49
6,705.45
Net Interest Income
1,737.23
2,569.49
2,531.89
-5,528.86
-6,527.34
EBIT
201,980.75
197,439.94
181,297.80
149,504.70
138,640.70
EBITDA
201,980.75
235,280.48
212,377.48
173,746.60
159,505.66
Reconciled Cost of Revenue
460,691.96
431,855.59
391,922.70
404,007.17
307,817.98
Reconciled Depreciation
22,976.05
37,840.54
31,079.68
24,241.90
20,864.96
Net Income from Continuing Operation Net Minority Interest
174,282.32
173,629.22
158,979.23
132,304.59
114,978.16
Total Unusual Items Excluding Goodwill
-9,982.18
-9,569.88
2,712.68
-1,319.16
-11,167.21
Total Unusual Items
-9,982.18
-9,569.88
2,712.68
-1,319.16
-11,167.21
Normalized EBITDA
211,962.93
244,850.35
209,664.80
175,065.76
170,672.86
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,367.91
-1,180.23
358.81
-103.17
-1,448.35
12/31/2021 - 11/16/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade